Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment | Zendy

Stefano Aquaro | Zendy; Roberta D’Arrigo | Zendy; Valentina Svicher | Zendy; Giovanni Di Perri | Zendy; Sergio Lo Caputo | Zendy; Ubaldo ViscoComandini | Zendy; Mario Santoro | Zendy; Ada Bertoli | Zendy; Francesco Mazzotta | Zendy; Stefano Bonora | Zendy; Valerio Tozzi | Zendy; Rita Bellagamba | Zendy; Mauro Zaccarelli | Zendy; Pasquale Narciso | Zendy; Andrea Antinori | Zendy; Carlo Federico Perno | Zendy

Open Access

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Author(s) -

Stefano Aquaro,

Roberta D’Arrigo,

Valentina Svicher,

Giovanni Di Perri,

Sergio Lo Caputo,

Ubaldo ViscoComandini,

Mario Santoro,

Ada Bertoli,

Francesco Mazzotta,

Stefano Bonora,

Valerio Tozzi,

Rita Bellagamba,

Mauro Zaccarelli,

Pasquale Narciso,

Andrea Antinori,

Carlo Federico Perno

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl306

Subject(s) - enfuvirtide , gp41 , regimen , medicine , human immunodeficiency virus (hiv) , virology , gastroenterology , immunology , biology , antigen , epitope

To investigate gp41 variability and correlation with viro-immunological parameters in 54 HIV-1-infected patients receiving enfuvirtide added as single active drug to a failing regimen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research